Skip to main content
. 2022 Jun 18;14(6):1298. doi: 10.3390/pharmaceutics14061298

Figure 2.

Figure 2

Percent remaining of (a) tegoprazan and (b) M1 following incubation with human liver microsomes (HLMs) and nicotinamide adenine dinucleotide phosphate (NADPH) cofactor.